alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
CAR REVIEW

REVIEWER OPTIONS

Request Revision Unapprove Section

Review Tips:

 Check the PR/Award Number for accuracy.

REPORT REVIEW

Cover Page

Note to Reviewer: Recipient Organization:

Organization Name: City:

Address 1: State:

Address 2: Zip Code:

1. Period covered by this report:

Start Date:

End Date:

2. PR/Award Numbers:

Title I Basic Grant to States:

3. Remarks: (Any explanation deemed necessary or information required by Federal sponsoring agency in compliance with governing legislation)

4. Lead individuals completing this report:

Select the lead individuals completing the report. If additional individuals without accounts will be completing the report, return to the Submit Your 

Report page and click "Request Access" to submit a request for additional user accounts.

1. Please select the individual responsible for the narrative performance information in this report
 

-- select user --

2. Please select the individual responsible for the financial status reports in this report:

 

-- select user --

3. Please select the individual responsible for the performance data in this report:

 

-- select user --

4. Please select the lead individual who may be contacted to answer questions about this report:

 

-- select user --

Public Burden Statement:

According to the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless such collection displays a valid 

OMB control number. The valid OMB control number for this information collection is 1830-0569. Public reporting burden for this collection of information is 

estimated to average 174 hours per response, including time for reviewing instructions, searching existing data sources, gathering and maintaining the data 

needed, and completing and reviewing the collection of information. The obligation to respond to this collection is required to obtain or retain benefit (Carl D. 

Perkins Career and Technical Education Act of 2006 (Perkins IV) (20 U.S. C. 2301 et seq. as amended by P.L. 109-270). If you have comments or concerns 

regarding the status of your individual submission of this APR, please contact (Office of Career, Technical and Adult Education; Director, Division of Academic 

and Technical Education; 550 12th Street, SW; Washington, D.C. 20202 directly. [Note: Please do not return the completed report to this address.]
#### State of Connecticut *v.*Arthur J. Davis

*Arthur J. Davis,*pro se, on the motions.

Submitted September 5

decided September 24, 1969

The motion by the defendant for a stay of execution is dismissed.

The motion by the defendant for a return of the transcript of the original trial in the Superior Court in New Haven County is dismissed.
<PAGE>


EXHIBIT 99.1:

CERTIFICATIONS PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


      In connection with the filing of the Quarterly Report on form 10-QSB for
      the Quarter Ended March 31, 2003 (the "Report") by Youbet.com, Inc., each
      of the undersigned hereby certifies that:

      1.    The Report complies in all material respects with the requirements
            of section 13(a) or 15(d) of the Securities Exchange Act of 1934, as
            amended, and

      2.    The information contained in the Report fairly presents, in all
            material respects, the financial condition and results of the
            operations of Registrant.



            May 15, 2003             By: /s/ Charles F. Champion
                                         ---------------------------
                                         Charles F. Champion
                                         President and Chief Executive Officer


            May 15, 2003             By: /s/ Gary Sproule
                                         ---------------------------
                                         Gary Sproule
                                         Chief Financial Officer

<PAGE>
#### STATE EX REL. CLIFFORD L. HILTON, ATTORNEY GENERAL v. A. J. VAN BUSKIRK.1

October 26, 1923.

No. 23,795.

Case followed.

Upon the relation of Clifford L. Hilton, Attorney General, the supreme court issued its writ of quo warranto directed to A. J. Buskirk requiring him to appear and show by what warrant he held the office of clerk of the city of Eveleth.

Writ quashed.

*Clifford L. Hilton,*Attorney General, and *GilMn & Manthey,*for relator.

*J. C. MeGilvery, George H. Spear*and *Boyle & Montague,*for respondent.

1

 Reported in 195 N. W. 542.

Per Curiam.

For the reasons stated in State ex rel. v. Essling, supra, page 15, the motion of the respondent to quash the writ of quo warranto issued in the above entitled proceeding must be granted, and it is accordingly ordered that such writ be and the same hereby is quashed.
Editorial Note on Part 25
Editorial Note: Nomenclature changes to part 25 appear at 88 FR 45065, July 14, 2023.

§ 25.22 Actions requiring the preparation of an environmental impact statement. ( a ) There are no categories of agency actions that routinely significantly affect the quality of the human environment and that therefore ordinarily require the preparation of an EIS.
( b ) EIS's are prepared for agency actions when evaluation of data or information in an EA or otherwise available to the agency leads to a finding by the responsible agency official that a proposed action may significantly affect the quality of the human environment.
# L_2019071EN.01003001.xml

| 13.3.2019 | EN | Official Journal of the European Union | L 71/30 |
| --- | --- | --- | --- |

13.3.2019

EN

Official Journal of the European Union

L 71/30

---

Corrigendum to Commission Implementing Regulation (EU) 2018/1565 of 17 October 2018 concerning the authorisation of a preparation of endo-1,4-beta-mannanase produced by Paenibacillus lentus (DSM 28088) as a feed additive for chickens for fattening, chickens reared for laying and minor poultry species other than laying birds, turkeys for fattening, turkeys reared for breeding, weaned piglets, pigs for fattening and minor porcine species (holder of authorisation Elanco GmbH)

(
  Official Journal of the European Union L 262 of 19 October 2018
  )

On page 26, in the Annex, in the fourth column ‘Composition, chemical formula, description, analytical method’; under ‘Additive composition’:

Additive composition

for:

| ‘— | 1,6 × 108 U (1)/g solid form; |
| --- | --- |

‘—

1,6 × 108 U (1)/g solid form;

8

1

| — | 5,9 × 108 U/g liquid form.’, |
| --- | --- |

—

5,9 × 108 U/g liquid form.’,

8

read:

| ‘— | 1,6 × 108 U (1)/kg solid form; |
| --- | --- |

‘—

1,6 × 108 U (1)/kg solid form;

8

1

| — | 5,9 × 108 U/L liquid form.’. |
| --- | --- |

—

5,9 × 108 U/L liquid form.’.

8

---
#### § 558.248 Erythromycin.

(a) *Specifications.* Type A medicated articles containing 92.5 grams per pound erythromycin (as the thiocyanate salt).

(b) *Sponsor.* See No. 061133 in § 510.600(c) of this chapter.

(c) *Related tolerances.* See § 556.230 of this chapter.

(d) *Special considerations.*

(1) Federal law restricts medicated feed containing this veterinary feed directive (VFD) drug to use by or on the order of a licensed veterinarian. See § 558.6 for additional requirements.

(2) The expiration date of VFDs for erythromycin medicated feeds must not exceed 6 months from the date of issuance. VFDs for erythromycin shall not be refilled.

(e) *Conditions of use* —

(1) *Chickens* —

| Erythromycin in grams/ton | Combination in grams/ton | Indications for use | Limitations | Sponsor |
| --- | --- | --- | --- | --- |
| (i) 92.5 | | Chickens: As an aid in the prevention of chronic respiratory disease during periods of stress | Feed for 2 days before stress and 3 to 6 days after stress. Withdraw 24 hours before slaughter | 061623 |
| (ii) 92.5 | | Chickens: As an aid in the prevention of infectious coryza | Feed for 7 to 14 days. Withdraw 24 hours before slaughter | 061623 |
| (iii) 185 | | Chickens: As an aid in the prevention and reduction of lesions and in lowering severity of chronic respiratory disease (CRD) | Feed for 5 to 8 days. Withdraw 48 hours before slaughter. Do not use in birds producing eggs for food | 061623 |

(2) *Turkeys* —

| Erythromycin thiocyanate in grams/ton | Combination in grams/ton | Indications for use | Limitations | Sponsor |
| --- | --- | --- | --- | --- |
| (i) 92.5 | | Turkeys: As an aid in the prevention of chronic respiratory disease during periods of stress | Feed for 2 days before stress and 3 to 6 days after stress | 061623 |
| (ii) 185 | | Turkeys: As an aid in the prevention and reduction of lesions and in lowering severity of chronic respiratory disease (CRD) | Feed for 5 to 8 days. Do not use in birds producing eggs for food | 061623 |

[41 FR 10999, Mar. 15, 1976, as amended at 45 FR 56799, Aug. 26, 1980; 49 FR 31281, Aug. 6, 1984; 51 FR 7397, Mar. 3, 1986; 52 FR 2684, Jan. 26, 1987; 54 FR 12189, Mar. 24, 1989; 66 FR 14074, Mar. 9, 2001; 68 FR 4915, Jan. 31, 2003; 79 FR 10982, Feb. 27, 2014; 81 FR 36790, June 8, 2016; 81 FR 95004, Dec. 27, 2016; 84 FR 8975, Mar. 13, 2019]
IN THE SUPREME COURT OF THE STATE OF MONTANA

DA 23-0677

_________________

JUAN ANASTASIO RODRIGUEZ,

 Petitioner and Appellant,

 v.

STATE OF MONTANA,

 Respondent and Appellee.

A M E N D E D

O R D E R

_________________

Pursuant to Appellant’s motion for a 120-day extension to time to file the opening 

brief and good cause appearing,

IT IS HEREBY ORDERED that Appellant is given an extension of time to and 

including August 20, 2024, to file the opening brief.

Electronically signed by:

Mike McGrath

Chief Justice, Montana Supreme Court

April 29 2024

04/29/2024

Case Number: DA 23-0677
# Appx A

# Appx B

# Appx C

# Appx D

# Appx E

# Appx F
NOTE: This disposition is nonprecedential.

 

United States Court of Appeals 

for the Federal Circuit ______________________ 

ENDOTACH LLC,

Plaintiff-Appellant

v.

COOK MEDICAL LLC,

Defendant-Appellee

______________________ 

2018-1347

______________________ 

Appeal from the United States District Court for the 

Southern District of Indiana in No. 1:13-cv-01135-RLMMJD, Senior Judge Robert L. Miller, Jr.

______________________ 

JUDGMENT

______________________ 

JONATHAN TAD SUDER, Friedman, Suder & Cooke, 

Fort Worth, TX, argued for plaintiff-appellant. Also 

represented by GLENN SCHUYLER ORMAN, BRETT MICHAEL 

PINKUS. 

 DOMINIC P. ZANFARDINO, Brinks Gilson & Lione, 

Chicago, IL, argued for defendant-appellee. Also represented by JEFFRY M. NICHOLS, JASON WAYNE SCHIGELONE. 

 ______________________ 
THIS CAUSE having been heard and considered, it is 

ORDERED and ADJUDGED: 

 PER CURIAM (DYK, REYNA, and HUGHES, Circuit 

Judges).

AFFIRMED. See Fed. Cir. R. 36.

 

 ENTERED BY ORDER OF THE COURT 

 

 October 9, 2018 /s/ Peter R. Marksteiner

 Date Peter R. Marksteiner

 Clerk of Court
# C_2014421EN.01006102.xml

| 24.11.2014 | EN | Official Journal of the European Union | C 421/61 |
| --- | --- | --- | --- |

24.11.2014

EN

Official Journal of the European Union

C 421/61

---

Action brought on 11 July 2014 — ZZ v Commission

(Case F-63/14)

2014/C 421/89

Language of the case: French

Parties

Parties

Applicants: ZZ and Others (represented by: S. Orlandi, lawyer)

Applicants:

Defendant: European Commission

Defendant:

Subject-matter and description of the proceedings

Subject-matter and description of the proceedings

Annulment of the decisions concerning the transfer of the applicants’ pension rights to the European Union pension scheme applying the new GIP on Articles 11 and 12 of Annex VIII to the Staff Regulations.

Form of order sought

Form of order sought

| — | Declare unlawful and therefore inapplicable Article 9 of the general implementing provisions of Article 11(2) of Annex VIII to the Staff Regulations; |
| --- | --- |

—

Declare unlawful and therefore inapplicable Article 9 of the general implementing provisions of Article 11(2) of Annex VIII to the Staff Regulations;

| — | Annul the decisions to credit the pension rights acquired by the applicants before taking up their duties, in the context of the transfer of those rights in the EU institutions’ pension scheme, pursuant to the general implementing provisions of Article 11(2) of Annex VIII to the Staff Regulations of 3 March 2011; |
| --- | --- |

—

Annul the decisions to credit the pension rights acquired by the applicants before taking up their duties, in the context of the transfer of those rights in the EU institutions’ pension scheme, pursuant to the general implementing provisions of Article 11(2) of Annex VIII to the Staff Regulations of 3 March 2011;

| — | Order the Commission to pay the costs. |
| --- | --- |

—

Order the Commission to pay the costs.

---
§ 520.622a Diethylcarbamazine citrate tablets. ( a ) *Sponsors.* ( 1 ) [Reserved]
( 2 ) See 054771 in § 510.600(c) of this chapter for use of 100, 200, and 300 milligram tablets for prevention of heartworm disease in dogs and as an aid in the treatment of ascarid infections in dogs.
( 3 ) See 061133 in § 510.600(c) of this chapter for use of 50, 100, 200, 300, or 400 milligram tablets for prevention of heartworm disease in dogs, as an aid in the control of ascarid infections in dogs, and as an aid in the treatment of ascarid infections in dogs and cats.
( 4 ) [Reserved]
( 5 ) See No. 000061 in § 510.600(c) of this chapter for use of 60, 120, or 180 milligram tablets for prevention of heartworm disease in dogs, as an aid in the control of ascarid infections in dogs, and as an aid in the treatment of ascarid infections in dogs and cats.
( 6 ) See No. 069043 in § 510.600(c) of this chapter for use of 50, 100, 200, 300, or 400 milligram tablets for prevention of heartworm disease in dogs, as an aid in the control of ascarid infections in dogs, and as an aid in the treatment of ascarid infections in dogs and cats.
( b ) *Conditions of use* — ( 1 ) *Dosage/indications for use.* ( i ) Three milligrams per pound of body weight daily for prevention of heartworm disease (*Dirofilaria immitis*) in dogs.
( ii ) Three milligrams per pound of body weight daily as an aid in the control of ascarid infections (*Toxocara canis*) in dogs.
( iii ) Twenty-five to 50 milligrams per pound of body weight as an aid in the treatment of ascarid infections in dogs (*Toxocara canis*) and cats (*Toxocara canis* and *Toxascaris leonina*).
( 2 ) *Limitations.* Federal law restricts this drug to use by or on the order of a licensed veterinarian.
[46 FR 23230, Apr. 24, 1981, as amended at 46 FR 41038, Aug. 14, 1981; 46 FR 46315, Sept. 18, 1981; 46 FR 61653, Dec. 18, 1981; 47 FR 10805, Mar. 12, 1982; 47 FR 14150, Apr. 2, 1982; 50 FR 41489, Oct. 11, 1985; 50 FR 49372, Dec. 2, 1985; 53 FR 40056, Oct. 13, 1988; 53 FR 40727, Oct. 18, 1988; 55 FR 8461, Mar. 8, 1990; 61 FR 34728, July 3, 1996; 62 FR 35076, June 30, 1997; 66 FR 14073, Mar. 9, 2001; 68 FR 4914, Jan. 31, 2003; 76 FR 17777, Mar. 31, 2011; 77 FR 4896, Feb. 1, 2012; 78 FR 21059, Apr. 7, 2013; 79 FR 28820, May 20, 2014; 83 FR 48945, Sept. 28, 2018; 84 FR 8972, Mar. 13, 2019]
**UN PUBLISHED** 
UNITED STATES COURT OF APPEALS FOR THE FOURTH CIRCUIT

**No. 15**  **- 7997** 

UNITED STATES OF AMERICA , Plaintiff

- Appellee ,
v. ANTHONY GENE TRAPPIER , Defendant

- Appellant
.

Appeal from the United States District Court for the District of South Carolina , at Florence
. Terry L. Wooten , Chief District Judge. ( 4:09

- cr - 00340

- TLW

- 1; 4:12

- cv - 03313

- TLW )

Submitted : April 21, 2016 Decided: April 26, 2016

Before WILKINSON, KING, and KEENAN , Circuit Judges.

Dismissed by un published per curiam opinion
. Anthony Gene Trappier, Appellant Pro Se. Robert Frank Daley, Jr., Assistant United States Attorney, Columbia, South Carolina, Arthur Bradley Parham, Assistant United States Attorney, Florence, South Carolina, for Appellee.
Unpublished opinions are not binding precedent in this circuit.2 PER CURIAM: Anthony Gene Trappier seeks to appeal the district court’s order denying relief on his 28 U.S.C. § 2255 ( 2012 ) motion , as well as its order denying his Fed. R. Civ. P. 59(e) mo tion . The order s are not appealable unless a circuit justice or judge issues a certificate of appealability. 28 U.S.C.
§ 2253(c)(1) (B) (20 12 ). A certificate of appealability will not issue absent “a substantial showing of the denial of a constitutional right.” 28 U.S.C. § 2253(c)(2) (20 12 ). When the district court denies relief on the merits, a prisoner satisfies this standard by demonstrating that reasonable jurists would find that the district court’s assessment of the constitutional claims is debata ble or wrong. Slack v. McDaniel , 529 U.S. 473, 484 (2000); see Miller

- El v. Cockrell , 537 U.S. 322, 336

- 38 (2003). When the district court denies relief on procedural grounds, the prisoner must demonstrate both that the dispositive procedural ruling is d ebatable, and that the motion states a debatable claim of the denial of a constitutional right. Slack , 529 U.S. at 484

- 85. We have independently reviewed the record and conclude that Trappier has not made the requisite showing. Accordingly, we deny a c ertificate of appealability and dismiss the appeal. We dispense with oral argument because the facts and legal3 contentions are adequately presented in the materials before th is court and argument would not aid the decisional process.

DISMISSED
§ 520.1010 Furosemide. ( a ) *Specifications.* ( 1 ) Each tablet contains 12.5 or 50 milligrams (mg) furosemide.
( 2 ) Each bolus contains 2 grams (g) furosemide.
( 3 ) Each packet of powder contains 2 g furosemide.
( 4 ) Each milliliter of syrup contains 10 mg furosemide.
( b ) *Sponsors.* See sponsor numbers in § 510.600(c) of this chapter for use of dosage forms and strengths listed in paragraph (a) of this section for uses as in paragraph (d) of this section. ( 1 ) No. 000010 for tablets in paragraph (a)(1) of this section for conditions of use in paragraphs (d)(2)(i), (d)(2)(ii)(A), and (d)(3) of this section.
( 2 ) No. 000061 for tablets in paragraph (a)(1) of this section for conditions of use in paragraphs (d)(2)(i), (d)(2)(ii)(A), and (d)(3) of this section; for boluses in paragraph (a)(2) of this section and powder in paragraph (a)(3) of this section for conditions of use in paragraph (d)(1) of this section; and for syrup in paragraph (a)(4) of this section for conditions of use in paragraphs (d)(2)(i) and (d)(2)(ii)(A).
( 3 ) Nos. 058829 and 069043 for use of syrup in paragraph (a)(4) of this section for conditions of use in paragraph (d)(2)(i) and (d)(2)(ii)(A) of this section.
( c ) *Special considerations.* Federal law restricts this drug to use by or on the order of a licensed veterinarian.
( d ) *Conditions of use.* It is used as follows: ( 1 ) *Cattle* — ( i ) *Amount.* 1 to 2 mg per pound (/lb) body weight using powder, or one 2-g bolus per animal, per day.
( ii ) *Indications for use.* For treatment of physiological parturient edema of the mammary gland and associated structures.
( iii ) *Limitations.* Treatment not to exceed 48 hours post-parturition. Milk taken during treatment and for 48 hours after the last treatment must not be used for food. Cattle must not be slaughtered for food within 48 hours following last treatment.
( 2 ) *Dogs* — ( i ) *Amount.* 1 to 2 mg/lb body weight, once or twice daily.
( ii ) *Indications for use.* ( A ) For treatment of edema (pulmonary congestion, ascites) associated with cardiac insufficiency and acute noninflammatory tissue edema.
( B ) For treatment of edema (pulmonary congestion, ascites) associated with cardiac insufficiency.
( 3 ) *Cats* — ( i ) *Amount.* 1 to 2 mg/lb body weight, once or twice daily.
( ii ) *Indications for use.* For treatment of edema (pulmonary congestion, ascites) associated with cardiac insufficiency and acute noninflammatory tissue edema.
[66 FR 47960, Sept. 17, 2001, as amended at 69 FR 74419, Dec. 14, 2004; 70 FR 50182, Aug. 26, 2005; 70 FR 76396, Dec. 27, 2005; 74 FR 61516, Nov. 25, 2009; 78 FR 17596, Mar. 22, 2013; 81 FR 17607, Mar. 30, 2016]
§ 74.1101 FD&C Blue No. 1 ( a ) *Identity.* ( 1 ) For ingested drugs, the color additive FD&C Blue No. 1 shall conform in identity to the requirements of § 74.101(a)(1).
( 2 ) For externally applied drugs, the color additive FD&C Blue No. 1 shall conform in identity to the requirements of § 74.2101(a).
( 3 ) Color additive mixtures for drug use made with FD&C Blue No. 1 may contain only those diluents that are suitable and that are listed in part 73 of this chapter as safe for use in color additive mixtures for coloring drugs.
( b ) *Specifications.* ( 1 ) The color additive FD&C Blue No. 1 for use in coloring drugs generally shall conform in specifications to the requirements of § 74.101(b).
( 2 ) FD&C Blue No. 1 Aluminum Lake shall be prepared in accordance with the requirements of § 82.51 of this chapter.
( c ) *Uses and restrictions.* ( 1 ) FD&C Blue No. 1 may be safely used for coloring drugs, including drugs intended for use in the area of the eye, in amounts consistent with current good manufacturing practice.
( 2 ) FD&C Blue No. 1 Aluminum Lake may be safely used for coloring drugs intended for use in the area of the eye, in amounts consistent with current good manufacturing practice, subject to the restrictions on the use of color additives in § 70.5(b) and (c) of this chapter.
( d ) *Labeling.* The label of the color additive and any mixtures prepared therefrom intended solely or in part for coloring purposes shall conform to the requirements of § 70.25 of this chapter.
( e ) *Certification.* All batches of FD&C Blue No. 1 shall be certified in accordance with regulations in part 80 of this chapter.
[47 FR 42565, Sept. 28, 1982, as amended at 59 FR 7638, Feb. 16, 1994]
# C_2015007EN.01005902.xml

| 12.1.2015 | EN | Official Journal of the European Union | C 7/59 |
| --- | --- | --- | --- |

12.1.2015

EN

Official Journal of the European Union

C 7/59

---

Action brought on 27 October 2014 — ZZ v Commission

(Case F-124/14)

(2015/C 007/76)

Language of the case: French

Parties

Parties

Applicant: ZZ (represented by: J.-N. Louis, R. Metz and D. Verbeke, lawyers)

Applicant:

Defendant: Commission

Defendant:

Subject-matter and description of the proceedings

Subject-matter and description of the proceedings

Annulment of the Commission’s decision not to increase the salary of the applicant, who is a member of the contract staff, in the light of the increase in working hours to 40 hours per week as a consequence of the entry into force of the new Staff Regulations on 1 January 2014.

Form of order sought

Form of order sought

The applicant claims that the Tribunal should:

| — | Annul the applicant’s salary statement for January 2014 and the statements for the subsequent months insofar as they do not provide for the additional monthly amount calculated in accordance with Articles 6 and 7 of the GIP No 1287 of 27 April 2005 and taking account of the increase in working hours; |
| --- | --- |

—

Annul the applicant’s salary statement for January 2014 and the statements for the subsequent months insofar as they do not provide for the additional monthly amount calculated in accordance with Articles 6 and 7 of the GIP No 1287 of 27 April 2005 and taking account of the increase in working hours;

| — | Order the Commission to pay the costs. |
| --- | --- |

—

Order the Commission to pay the costs.

---